8994 Federal Register / Vol. 62, No. 39 / Thursday, February 27, 1997 / Notices

Drug Schedule

Methylphenidate (1724) .................. II

Amobarbital (2125) ......................... II

Pentobarbital (2270) ....................... II

Secobarbital (2315) ........................ II

Glutethimide (2550) ........................ II

Methadone (9250) .......................... II

Methadone-intermediate (9254) ..... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

DEA has considered the factors in 21

U.S.C. § 823(a) as well as information

provided by other bulk manufacturers,

and determined that the registration of

Ganes Chemicals, Inc. to manufacture

the listed controlled substances is

consistent with the public interest at

this time. Therefore, pursuant to 21

U.S.C. § 823 and 28 C.F.R. §§ 0.100 and

0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: February 21, 1997.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–4895 Filed 2–26–97; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated October 21, 1996, and

published in the Federal Register on

November 14, 1996, (61 FR 58424),

Norac Company, Inc., 405 S. Motor

Avenue, Azusa, California 91702, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

tetrahydrocannabinols (7370), a basic

class of controlled substance listed in

Schedule I.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Norac, Company, Inc. to

manufacturer tetrahydrocannabinols is

consistent with the public interest at

this time. Therefore, pursuant to 21

U.S.C. § 823 and 28 C.F.R. §§ 0.100 and

0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated February 6, 1997.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–4897 Filed 2–26–97; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated October 21, 1996, and

published in the Federal Register on

November 14, 1996, (61 FR 58424),

Nycomed, Inc., 33 Riverside Avenue,

Rensselaer, New York 12144, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

meperidine (9230), a basic class of

controlled substance listed in Schedule

II.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Nycomed, Inc. to

manufacture meperidine is consistent

with the public interest at this time.

Therefore, pursuant to 21 U.S.C. § 823

and 28 CFR §§ 0.100 and 0.104, the

Deputy Assistant Administrator, Office

of Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic class of

controlled substance listed above is

granted.

Dated: February 7, 1997.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–4896 Filed 2–26–97; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated July 31, 1996, and

published in the Federal Register on

August 8, 1996, (61 FR 41427), U.S.

Drug Testing, Inc., 10410 Trademark

Street, Rancho Cucamonga, California

91730, made application by renewal to

the Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ................................................................................................................................................................... I

Heroin (9200) ............................................................................................................................................................................................. I

Amphetamine (1100) ................................................................................................................................................................................. II

Methamphetamine (1105) .......................................................................................................................................................................... II

Phencyclidine (7471) ................................................................................................................................................................................. II

1–Piperidinocyclohexanecarbonitrile (8603) .............................................................................................................................................. II

Benzoylecgonine (9180) ............................................................................................................................................................................ II

Morphine (9300) ......................................................................................................................................................................................... II

DEA has considered the factors in 21

U.S.C. 823(a), as well as information

provided by other bulk manufacturers,

and determined that the registration of

U.S. Drug Testing, Inc. to manufacture

the listed controlled substances is

consistent with the public interest at

this time. Therefore, pursuant to 21

U.S.C. 823 and 28 C.F.R. 0.100 and

0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–4894 Filed 2–26–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF LABOR

Employment Standards Administration

Proposed Collection; Comment

Request

ACTION: Notice.

SUMMARY: The Department of Labor, as

part of its continuing effort to reduce

paperwork and respondent burden,

conducts a preclearance consultation

program to provide the general public

and Federal agencies with an
Federal Register / Vol. 62, No. 39 / Thursday, February 27, 1997 / Notices 8995

opportunity to comment on proposed

and/or continuing collections of

information in accordance with the

Paperwork Reduction Act of 1995

(PRA95) [44 U.S.C. 3506(c)(2)(A)]. This

program helps to ensure that requested

data can be provided in the desired

format, reporting burden (time and

financial resources) is minimized,

collection instruments are clearly

understood, and the impact of collection

requirements on respondents can be

properly assessed. Currently, the

Employment Standards Administration

is soliciting comments concerning two

proposed extension information

collections: (1) the Notice of Final

Payment or Suspension of

Compensation Benefits (LS–208) and (2)

Request for Earnings Information (LS–

426).

Copies of the proposed information

collection requests can be obtained by

contacting the office listed below in the

addressee section of this notice.

DATES: Written comments must be

submitted to the office listed in the

addressee section below on or before

April 28, 1997. The Department of Labor

is particularly interested in comments

which:

* evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

* evaluate the accuracy of the agency’s

estimate of the burden of the proposed

collection of information, including the

validity of the methodology and

assumptions used;

* enhance the quality, utility and

clarity of the information to be

collected; and

* minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submissions

of responses.

ADDRESSES: Ms. Margaret Sherrill, U.S.

Department of Labor, 200 Constitution

Ave., N.W., Room S–3201, Washington,

D.C. 20210, telephone (202) 219–7601.

(This is not a toll-free number.), Fax

202–219–6592.

SUPPLEMENTARY INFORMATION:

I. Background

Under Section 14(g) of the Longshore

and Harbor Workers Compensation Act

(LHWCA), the employer or its insurance

carrier must file a report of the

compensation paid to a claimant at the

time final payment is made. The Act

requires that the form must be filed

within sixteen days of the final payment

of compensation with the District

Director in the compensation district in

which the injury occurred. The form

requests information regarding the

beginning and ending dates of

compensation payments, compensation

rates, reason payments were terminated

and types and amount of compensation

payments. Filing of the report is

mandatory as failure to do so is subject

to a civil penalty.

II. Current Actions

The Department of Labor (DOL) seeks

extension of approval to collect this

information in order to carry out its

responsibility to notify Office of

Workers’ Compensation Programs

(OWCP) District Offices that payment of

compensation benefits has been stopped

or suspended in a case. The report is

required by law. If the report were not

filed, our offices would have no way to

determine whether payments have been

suspended in a case and therefore

would not be able to effectively manage

the case file and verify that the injured

worker had received all benefits that he/

she is entitled to receive under the Act.

Type of Review: Extension.

Agency: Employment Standards

Administration.

Title: Notice of Final Payment or

Suspension of Compensation Benefits.

OMB Number: 1215–0024.

Agency Numbers: LS–208.

Affected Public: Business or other forprofit.

Total Respondents: 500.

Frequency: On occasion.

Total Responses: 28,000.

Average Time Per Response for

Reporting: 15 minutes.

Estimated Total Burden Hours: 7,000.

Total Burden Cost (capital/startup): 0.

Total Burden Cost (operating/

maintenance): $700.

I. Background

Pursuant to Section 8 of the LHWCA,

injured employees shall receive

compensation in an amount equal to 66

and two-thirds percent of their average

weekly wage. Form LS–426 is used to

verify the average weekly wage of an

injured employee to determine if the

correct compensation rate is being paid.

Pursuant to Section 10 of the Act, the

average weekly wage of the injured

employee may be determined by using

those wages earned in the occupation

which the injury occurred or wages

earned in different occupations.

Depending on whether similar or other

employment is involved, the average

weekly wage will be determined under

either Section 10 (a), (b), or (c) of the

Act.

II. Current Actions

The Department of Labor seeks

extension of approval to collect this

information to assure that injured

workers are paid at the proper

compensation rate. The form benefits

the injured worker. It provides a simple

method for him/her to provide the

OWCP with prior earnings information.

If the information were not collected,

injured workers would not be paid the

proper compensation rate in all cases.

Type of Review: Extension.

Agency: Employment Standards

Administration.

Title: Request for Earnings

Information.

OMB Number: 1215–0112.

Affected Public: Individuals or

households.

Total Respondents: 1,900.

Frequency: On occasion.

Total Responses: 1,900.

Average Time Per Response for

Reporting: 15 minutes.

Estimated Total Burden Hours: 475.

Total Burden Cost (capital/startup):

$0.

Total Burden Cost (operating/

maintenance): $665.

Comments submitted in response to

this notice will be summarized and/or

included in the request for Office of

Management and Budget approval of the

information collection requests; they

will also become a matter of public

record.

Dated: February 21, 1997.

Cecily A. Rayburn,

Director, Division of Financial Management,

Office of Management, Administration and

Planning, Employment Standards

Administration.

[FR Doc. 97–4790 Filed 2–26–97; 8:45 am]

BILLING CODE 4510–27–M

NATIONAL COUNTERINTELLIGENCE

CENTER

Privacy Act of 1974; Establishment of

a New System of Records

AGENCY: National Counterintelligence

Center (NACIC).

ACTION: Proposed establishment of a

new Privacy Ace system of records.

SUMMARY: The National

Counterintelligence Center (NACIC)

proposes to establish a new system of

records entitled the National

Counterintelligence Center System of

Records. Federal Agencies are required

by the Privacy Act of 1974 and Office

of Management and Budget Circular A–